Doctors Note Logo

Published on: 9/13/2026

Is hydroxyzine addictive or dangerous for my heart if I take it long term?

Hydroxyzine is not a controlled substance and is not considered addictive, so it does not cause the cravings, tolerance, or withdrawal seen with benzodiazepines, though your heart deserves a closer look because hydroxyzine can prolong the QT interval and, in rare cases, trigger a dangerous arrhythmia. Risk rises with higher doses, older age, existing heart disease or slow heart rhythm, low potassium or magnesium, and combining it with other QT-prolonging medications, while long-term use can also bring anticholinergic effects like heavy sedation, dry mouth, constipation, and memory changes. Several important factors determine whether extended use is safe for you, so see below for the complete details before drawing conclusions.

Because symptoms like palpitations, dizziness, fainting, or unusual fatigue while taking hydroxyzine can point to either a harmless side effect or a heart rhythm problem that needs prompt attention, it helps to sort out what is actually happening before your next appointment. Take a free, instant, online symptom check to better understand your symptoms and figure out the right next steps.

Last reviewed for medical accuracy: 09/12/2026

answer background

Explanation

Hydroxyzine: Addiction and Heart Safety in Long-Term Use

Hydroxyzine is a prescription antihistamine often used to manage allergy symptoms, anxiety, nausea, itching and sleep disturbances. If you’re prescribed hydroxyzine for weeks, months or longer, you may wonder:

  1. Can I become dependent on it?
  2. Will it harm my heart over time?

Below, we review credible medical data to help you understand how hydroxyzine works, its potential for dependence and its cardiac safety profile when taken long term.


How Hydroxyzine Works

  • It blocks histamine H1 receptors, reducing allergy-related symptoms (itching, hives, runny nose).
  • It has sedative effects by crossing into the central nervous system, which is why it’s sometimes used for anxiety or insomnia.
  • Unlike benzodiazepines or opioids, hydroxyzine does not directly target GABA or opioid receptors.

Is Hydroxyzine Addictive?

Key Points

  • No classic “addiction” profile.
    • Hydroxyzine is not classified as a controlled substance.
    • It does not trigger the dopamine-reward pathway like opioids or stimulants.
  • No physical dependence or withdrawal syndrome.
    • Users generally do not experience cravings, drug-seeking behaviors or withdrawal symptoms when stopping hydroxyzine.
  • Tolerance may occur in some.
    • A few people notice diminished sedative effects over time, but this does not reflect physical dependence.
    • Tolerance is often mild and may be managed by adjusting dosage under medical supervision.

What the Research Shows

  • Published clinical reviews and FDA-approved prescribing information report no evidence of hydroxyzine abuse or dependence in both short-term and long-term studies.
  • Sedation may lessen after several weeks, but that’s a pharmacologic adaptation, not an addiction.

Bottom line: Hydroxyzine is not addictive in the way benzodiazepines or opioids are. You won’t experience a classic withdrawal syndrome, and it isn’t a controlled substance.


Cardiac Safety of Long-Term Hydroxyzine Use

QT Prolongation Concerns

  • Definition: The QT interval is a measure on an electrocardiogram (ECG) that reflects the time it takes for your heart’s lower chambers to repolarize (reset) between beats. Prolonging this interval can predispose to arrhythmias.
  • Hydroxyzine’s effect: At higher doses—particularly above 100 mg per day—or with rapid intravenous administration, hydroxyzine can lengthen the QT interval.
  • Risk factors that raise concern:
    • Pre-existing heart disease or congenital long QT syndrome
    • Electrolyte imbalances (low potassium, magnesium)
    • Concurrent use of other QT-prolonging drugs (certain antidepressants, antipsychotics, macrolide antibiotics)
    • Severe liver or kidney impairment (slows drug clearance)

Data on Long-Term Oral Use

  • Recommended doses (25–50 mg daily): Studies and post-marketing surveillance show a very low incidence of serious arrhythmias in otherwise healthy adults.
  • High-dose therapy: Caution is advised above 100 mg/day. Your doctor may:
    • Order periodic ECGs
    • Monitor electrolytes
    • Adjust dose if you have known cardiac risk factors

Monitoring and Prevention

  • Tell your doctor if you have a history of heart rhythm problems, structural heart disease or electrolyte disturbances.
  • If you’re taking other medications, review them for QT-prolonging potential.
  • Report symptoms such as palpitations, fainting or unusual dizziness promptly.

Bottom line: At standard oral doses, hydroxyzine is generally safe for the heart. In higher doses or in the presence of other risk factors, there is a small risk of QT prolongation that doctors can mitigate with monitoring.


Practical Tips for Safe, Long-Term Use

  1. Follow the prescribed dose.
    – Don’t increase your dose on your own if sedation seems to wane. Talk to your doctor first.
  2. Schedule regular check-ins.
    – Routine visits let your doctor assess effectiveness, check for side effects and adjust dosing.
  3. Review other medications.
    – Share a full list of prescriptions, over-the-counter drugs and supplements to avoid interactions.
  4. Stay hydrated and maintain electrolytes.
    – Drinks rich in potassium (bananas, potatoes) and magnesium (leafy greens, nuts) help protect your heart.
  5. Watch for warning signs.
    – Unexplained chest pain, new-onset palpitations, fainting or near-fainting should prompt immediate medical attention.

When to Seek Further Evaluation

If you ever feel uncertain about your symptoms—whether it’s new heart-related sensations, unexpected side effects or persistent anxiety—consider a quick free, online symptom check, using the doctor approved Ubie Symptom Checker. It can guide you on whether to seek urgent care or schedule a doctor’s appointment.

Free, online symptom check, using the doctor approved Ubie Symptom Checker


Summary

  • Hydroxyzine is not addictive in the way opioids or benzodiazepines are. You won’t develop classic physical dependence or withdrawal.
  • At standard oral doses, long-term use carries a low risk of heart rhythm issues.
  • High doses, rapid IV use or underlying heart conditions can increase the chance of QT prolongation—but your doctor can monitor and manage these risks.
  • Always take hydroxyzine exactly as prescribed, maintain regular follow-ups and report any concerning symptoms.

Speak to a doctor if you experience any life-threatening or serious issues, such as fainting spells, chest pain or severe allergic reactions. Your healthcare provider can tailor advice to your medical history and ensure your treatment stays both safe and effective.

(References)

  • * Fexofenadine: new preparation. Terfenadine, without cardiotoxicity. Prescrire Int. 1999 Feb;8(39):11-3. PMID: 10557567.

  • * Limdiwala PG, Parikh SJ, Shah JS. Sweet's syndrome. Indian J Dent Res. 2014 May-Jun;25(3):401-5. doi: 10.4103/0970-9290.138358. PMID: 25099003.

  • * Paterson NE, Darby WC, Sandhu PS. N,N-Dimethyltryptamine-Induced Psychosis. Clin Neuropharmacol. 2015 Jul-Aug;38(4):141-3. doi: 10.1097/WNF.0000000000000078. PMID: 26166234.

  • * Meeuwis SH, van Middendorp H, Pacheco-Lopez G, Ninaber MK, Lavrijsen APM, van der Wee N, Veldhuijzen DS, Evers AWM. Antipruritic Placebo Effects by Conditioning H1-antihistamine. Psychosom Med. 2019 Nov/Dec;81(9):841-850. doi: 10.1097/PSY.0000000000000743. PMID: 31490841; PMCID: PMC6844655.

  • * Renko A, Cortese T, Karagiannis P, Salzman M. Unintentional cetirizine overdose causing anticholinergic syndrome. Am J Emerg Med. 2022 Feb;52:270.e1-270.e3. doi: 10.1016/j.ajem.2021.08.062. Epub 2021 Aug 25. PMID: 34474941.

  • * Siddiqui MZ, Piserchio JP, Patel M, Park J, Foster ML, Desrosiers CE, Herbert J, Nichols SD, McCall KL, Piper BJ. Examination of multiple drug arrests reported to the Maine Diversion Alert Program. Forensic Sci Med Pathol. 2022 Jun;18(2):133-140. doi: 10.1007/s12024-021-00454-1. Epub 2022 Jan 30. PMID: 35094290; PMCID: PMC11095619.

  • * Burgazli CR, Rana KB, Brown JN, Tillman F 3rd. Efficacy and safety of hydroxyzine for sleep in adults: Systematic review. Hum Psychopharmacol. 2023 Mar;38(2):e2864. doi: 10.1002/hup.2864. Epub 2023 Feb 26. PMID: 36843057.

  • * Adamowicz P, Bigosińska J, Gil D, Suchan M, Tokarczyk B. Drugs detection in fingerprints. J Pharm Biomed Anal. 2024 Jan 20;238:115835. doi: 10.1016/j.jpba.2023.115835. Epub 2023 Nov 2. PMID: 37926037.

  • * Dumas E, Grandal Rejo B, Gougis P, Houzard S, Abécassis J, Jochum F, Marande B, Ballesta A, Del Nery E, Dubois T, Alsafadi S, Asselain B, Latouche A, Espie M, Laas E, Coussy F, Bouchez C, Pierga JY, Le Bihan-Benjamin C, Bousquet PJ, Hotton J, Azencott CA, Reyal F, Hamy AS. Concomitant medication, comorbidity and survival in patients with breast cancer. Nat Commun. 2024 Apr 5;15(1):2966. doi: 10.1038/s41467-024-47002-3. Epub 2024 Apr 5. PMID: 38580683; PMCID: PMC10997660.

  • * Ben-Shoshan M, Cem A, Cook VE, Khalaf R, Freigeh G. Idiopathic Anaphylaxis. J Allergy Clin Immunol Pract. 2025 Dec;13(12):3165-3178.e1. doi: 10.1016/j.jaip.2025.08.019. Epub 2025 Aug 27. PMID: 40882893.

Thinking about asking ChatGPT?Ask me instead

Tell your friends about us.

We would love to help them too.

smily Shiba-inu looking

For First Time Users

What is Ubie’s Doctor’s Note?

We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.

Was this page helpful?

Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.